Amivantamab Plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
Byoung C. Cho,Shun Lu,Enriqueta Felip,Alexander I. Spira,Nicolas Girard,Jong-Seok Lee,Se-Hoon Lee,Yurii Ostapenko,Pongwut Danchaivijitr,Baogang Liu,Adlinda Alip,Ernesto Korbenfeld,Josiane Mourao Dias,Benjamin Besse,Ki-Hyeong Lee,Hailin Xiong,Soon-Hin How,Ying Cheng,Gee-Chen Chang,Hiroshige Yoshioka,James C. -H. Yang,Michael Thomas,Danny Nguyen,Sai-Hong I. Ou, Sanjay Mukhedkar,Kumar Prabhash,Manolo D'Arcangelo,Jorge Alatorre-Alexander, Juan C. Vazquez Limon, Sara Alves,Daniil Stroyakovskiy, Marina Peregudova,Mehmet A. N. Sendur,Ozan Yazici,Raffaele Califano, Vanesa Gutierrez Calderon,Filippo de Marinis,Antonio Passaro,Sang-We Kim,Shirish M. Gadgeel,John Xie,Tao Sun,Melissa Martinez, Mariah Ennis, Elizabeth Fennema,Mahesh Daksh,Dawn Millington, Isabelle Leconte,Ryota Iwasawa,Patricia Lorenzini,Mahadi Baig, Sujay Shah,Joshua M. Bauml,S. Martin Shreeve, Seema Sethi,Roland E. Knoblauch,Hidetoshi Hayashi The New England journal of medicine（2025）
AI 理解论文
溯源树
样例
